3 Promising Penny Stocks With Market Caps Over US$100M

As global markets experience mixed performances, with major indexes like the S&P 500 and Nasdaq Composite reaching record highs while others like the Russell 2000 face declines, investors are keenly observing sector shifts and economic indicators. In this context, penny stocks—often seen as relics of past market eras—continue to offer intriguing investment opportunities. These smaller or newer companies can provide a blend of affordability and potential growth when supported by robust financial health. Today, we explore three penny stocks that stand out for their financial strength and potential to uncover hidden value in quality companies.

Top 10 Penny Stocks

Name	Share Price	Market Cap	Financial Health Rating
DXN Holdings Bhd (KLSE:DXN)	MYR0.51	MYR2.54B	★★★★★★
Embark Early Education (ASX:EVO)	A$0.78	A$143.12M	★★★★☆☆
Datasonic Group Berhad (KLSE:DSONIC)	MYR0.425	MYR1.18B	★★★★★★
Hil Industries Berhad (KLSE:HIL)	MYR0.90	MYR298.75M	★★★★★★
ME Group International (LSE:MEGP)	£2.16	£806.27M	★★★★★★
Bosideng International Holdings (SEHK:3998)	HK$4.02	HK$44.27B	★★★★★★
LaserBond (ASX:LBL)	A$0.575	A$67.4M	★★★★★★
Lever Style (SEHK:1346)	HK$0.87	HK$545.92M	★★★★★★
Secure Trust Bank (LSE:STB)	£3.53	£67.32M	★★★★☆☆
Tristel (AIM:TSTL)	£3.65	£183.61M	★★★★★★

Click here to see the full list of 5,700 stocks from our Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Vista Group International (NZSE:VGL)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Vista Group International Limited offers software and data analytics solutions to the global film industry, with a market capitalization of NZ$701.14 million.

Operations: The company's revenue is primarily generated from the United States (NZ$51.7 million), the United Kingdom (NZ$38.4 million), New Zealand (NZ$25.6 million), and Mexico (NZ$11.7 million).

Market Cap: NZ$701.14M

Vista Group International, with a market capitalization of NZ$701.14 million, is navigating financial challenges as it remains unprofitable and has seen losses increase by 5.2% annually over the past five years. Despite this, the company maintains a satisfactory net debt to equity ratio of 0.07% and its short-term assets (NZ$57.4M) exceed both short-term (NZ$48M) and long-term liabilities (NZ$24.2M). The board's experience averages 9.2 years, while management shows stability with an average tenure of 2.5 years, amidst recent investor activism that led to significant boardroom discussions but no immediate changes in leadership structure.

• Click to explore a detailed breakdown of our findings in Vista Group International's financial health report.
• Gain insights into Vista Group International's future direction by reviewing our growth report.

Perfect Medical Health Management (SEHK:1830)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Perfect Medical Health Management Limited is an investment holding company that provides medical, aesthetic medical, and beauty and wellness services across Hong Kong, the People's Republic of China, Macau, Australia, and Singapore with a market cap of approximately HK$3.01 billion.

Operations: The company generates revenue of HK$1.30 billion from its services in medical, aesthetic medical, and beauty and wellness sectors.

Market Cap: HK$3.01B

Perfect Medical Health Management, with a market cap of HK$3.01 billion, has demonstrated robust financial health despite recent challenges. The company reported half-year sales of HK$620.27 million and net income of HK$140.84 million, reflecting a decline from the previous year. Its strong return on equity at 62.3% and absence of debt underscore financial resilience, while short-term assets exceed both long-term and short-term liabilities comfortably. However, profits have declined by 2.7% annually over five years, raising concerns about growth sustainability despite forecasts suggesting future earnings improvement at 16.58% per year amidst dividend reductions to HKD 0.112 per share recently announced.

• Dive into the specifics of Perfect Medical Health Management here with our thorough balance sheet health report.
• Assess Perfect Medical Health Management's future earnings estimates with our detailed growth reports.

Peninsula Group (TASE:PEN)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Peninsula Group Ltd offers credit solutions in Israel and has a market cap of ₪486.76 million.

Operations: The company's revenue from its financial services segment, specifically commercial activities, amounts to ₪99.59 million.

Market Cap: ₪486.76M

Peninsula Group Ltd, with a market cap of ₪486.76 million, has shown mixed financial performance. Its short-term assets of ₪1.5 billion comfortably cover both its short and long-term liabilities, indicating solid liquidity. However, the company faces challenges with high net debt to equity at 125.2% and low return on equity at 9.2%. Despite these issues, Peninsula maintains a high dividend yield of 7.33%, appealing to income-focused investors. Recent earnings reports revealed an increase in quarterly net income to ₪15.16 million from ₪11.68 million last year but showed a decline for the nine-month period compared to the previous year.

• Click here to discover the nuances of Peninsula Group with our detailed analytical financial health report.
• Examine Peninsula Group's past performance report to understand how it has performed in prior years.

Turning Ideas Into Actions

• Click this link to deep-dive into the 5,700 companies within our Penny Stocks screener.
• Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
• Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Jump on the AI train with fast growing tech companies forging a new era of innovation.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com